Ledger.Open graph →
SEC Form D · Amendment · filed February 7, 2014

BioAegis Therapeutics, Inc

Offering
$6.0M
Sold
$3.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MORRISTOWN, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Thomas Stossel · Morristown, NJDirectorSusan Levinson · Morristown, NJExec · DirectorSteve Cordovano · Morristown, NJExecValerie Ceva · Morristown, NJExec · DirectorJames A. Rogers · ANCHORAGE, AKExecRichard Slaughter · San Diego, CADirectorCharles B. Krusen · NEW YORK, NYExec · DirectorNicholas D. Smith · SEBASTOPOL, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗